Scinai Immunotherapeutics (SCNI) Shareholder's Equity (2018 - 2025)

Scinai Immunotherapeutics (SCNI) Shareholder's Equity (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Scinai Immunotherapeutics 3.02 Bn 988.23 Mn - 8.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.10 Mn
Dec 31, 2024 9.98 Mn
Dec 31, 2023 -4.57 Mn
Mar 31, 2023 -4.81 Mn
Dec 31, 2022 -1.76 Mn
Sep 30, 2022 747.15 Mn
Mar 31, 2022 -862,000.00
Dec 31, 2021 982,000.00
Sep 30, 2021 1.30 Mn
Dec 31, 2020 -15.04 Mn
Sep 30, 2020 -535,000.00
Jun 30, 2020 -17.87 Mn
Dec 31, 2019 -18.82 Mn
Dec 31, 2018 -8.33 Mn